FT Health Discusses Germany’s Role In G20, Features Interview With GHIT’s BT Slingsby

FT Health: Germany takes leadership on global health
The latest issue of the Financial Times’ weekly global health newsletter discusses Germany’s role at the G20 Summit, noting, “Germany has stepped up its funding and provided focus, notably around strengthening the response to the rising threat of antibiotic drug resistance. This year’s holder of the G20 presidency has also worked to boost the international system that identifies and responds to new infectious disease threats, from flu to Zika.” The newsletter also features an interview with Global Health Innovative Technology Fund (GHIT) CEO BT Slingsby,  as well as provides a roundup of global-health related news stories (Jack, 7/7).